Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWh Smith Regulatory News (SMWH)

Share Price Information for Wh Smith (SMWH)

Share Price is delayed by 15 minutes
Get Live Data
506.00    -2.00 (-0.39%)
Bid:
503.50
Ask:
505.00
Spread: 1.50 (0.298%)
Market Cap: £630.96m
SMWH Live PriceLast checked at - London Stock Exchange

Intraday Wh Smith Share Chart

Successful completion of refinancing

25 Mar 2025 07:00

RNS Number : 9368B
WH Smith PLC
25 March 2025
 

WH Smith PLC

 

The global travel retailer

  

25 March 2025

 

Successful completion of refinancing

 

WH Smith PLC ('WHSmith' or the 'Group'), the global travel retailer, today announces the successful completion of a £200m issue of US Private Placement (USPP) notes and a bank term loan of £120m.

The USPP notes, which represent WHSmith's debut issue in the USPP market, have a maturity of seven, ten and twelve years and have been issued on investment grade terms. At the same time, WHSmith has agreed a £120m three-year bank term loan with two uncommitted extension options of one year each, which would, subject to lender approval, extend the tenor of the new bank loan to four and five years, if exercised. The additional bank loan is provided by a syndicate of existing lending banks comprising: Fifth Third Bank National Association, HSBC UK Bank PLC, Banco Santander SA, London and Skandinaviska Enskilda Banken AB (PUBL).

The Group's existing £400m revolving credit facility ('RCF') is retained and matures in June 2029. The RCF has one remaining uncommitted extension option of one year, which would, subject to lender approval, extend the maturity date to June 2030, if exercised.

This refinancing will diversify the Group's sources of debt financing and extends the Group's debt maturity profile in advance of the convertible bond maturing on 7 May 2026. The income statement cost of the convertible bond is c.4.6% including the non-cash debt accretion charge. The income statement cost of the replacement financing will be c.6.3%.

 

Max Izzard, Group Chief Financial Officer, WHSmith, commented:

"We are pleased to have successfully completed our refinancing, which includes our first US Private Placement and a new bank term loan. The refinancing strengthens our balance sheet, extends our debt maturity profile, and diversifies our capital structure. It also gives the Group access to a new debt investor base in the future, and we are pleased to have the continuing support of our banking partners."

 

 

Enquiries:

 

WH Smith PLC

Nicola Hillman Media Relations +44 1793 563354

Mark Boyle Investor Relations +44 7879 897687

 

Brunswick

Tim Danaher +44 20 7404 5959

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDPPUCCWUPAGQC
Date   Source Headline
4th Jun 20269:23 amRNSHolding(s) in Company
29th May 202611:00 amRNSTotal Voting Rights
20th May 20265:12 pmRNSDirector/PDMR Shareholding
30th Apr 202611:08 amRNSTotal Voting Rights
29th Apr 202610:25 amRNSHolding(s) in Company
29th Apr 202610:19 amRNSHolding(s) in Company
27th Apr 20263:57 pmRNSDirector/PDMR Shareholding
23rd Apr 20267:01 amRNSBoard changes
23rd Apr 20267:00 amRNSInterim Results Announcement
17th Apr 202611:06 amRNSHolding(s) in Company
16th Apr 202612:51 pmRNSHolding(s) in Company
16th Apr 20267:16 amRNSHolding(s) in Company
14th Apr 20266:03 pmRNSHolding(s) in Company
9th Apr 202610:11 amRNSHolding(s) in Company
7th Apr 20267:00 amRNSDirectorate change
31st Mar 202612:50 pmRNSTotal Voting Rights
23rd Mar 20269:21 amRNSHolding(s) in Company
9th Mar 20269:59 amRNSHolding(s) in Company
5th Mar 20267:00 amRNSTrading update
27th Feb 202611:00 amRNSTotal Voting Rights
25th Feb 202610:32 amRNSBlock Listing Six Monthly Return
12th Feb 20269:17 amRNSNotice of GM
3rd Feb 20269:56 amRNSResult of AGM
30th Jan 202611:00 amRNSTotal Voting Rights
29th Jan 20264:41 pmRNSDirector/PDMR Shareholding
22nd Jan 202611:35 amRNSHolding(s) in Company
19th Jan 202611:58 amRNSHolding(s) in Company
19th Jan 20269:57 amRNSHolding(s) in Company
19th Jan 20269:53 amRNSHolding(s) in Company
19th Jan 20267:00 amRNSAppointment of Executive Chairman
9th Jan 202610:27 amRNSDirector Declaration
8th Jan 20264:36 pmRNSDirector/PDMR Shareholding
31st Dec 202511:00 amRNSTotal Voting Rights
31st Dec 202511:00 amRNSTotal Voting Rights
24th Dec 20251:29 pmRNSDirector/PDMR Shareholding
24th Dec 20251:29 pmRNSDirector/PDMR Shareholding
24th Dec 20251:24 pmRNSDirector/PDMR Shareholding
24th Dec 20251:24 pmRNSDirector/PDMR Shareholding
24th Dec 20251:22 pmRNSAnnual Financial Report
24th Dec 20251:22 pmRNSAnnual Financial Report
24th Dec 20251:16 pmRNSDirector/PDMR Shareholding
24th Dec 20251:16 pmRNSDirector/PDMR Shareholding
23rd Dec 202512:05 pmRNSHolding(s) in Company
23rd Dec 202512:05 pmRNSHolding(s) in Company
19th Dec 20259:14 amRNSDirectorate change
19th Dec 20259:14 amRNSDirectorate change
19th Dec 20257:00 amRNSPreliminary Results Announcement
19th Dec 20257:00 amRNSPreliminary Results Announcement
12th Dec 20257:00 amRNSRevised date of Preliminary Results publication
28th Nov 202510:11 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.